Evidence map›Paper›PMID 34950904›Full record

ReviewPatterns (New York, N.Y.)2021

Labels in a haystack: Approaches beyond supervised learning in biomedical applications.

Artur Yakimovich, Anaël Beaugnon, Yi Huang, Elif Ozkirimli

Abstract readReview
In one paragraph

Review in Patterns (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Large Language Models in Bio-Ontology Research: A Review.Bioengineering (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Artur YakimovichRoche Pharma International Informatics, Roche Products Limited, Welwyn Garden City, UK.
Anaël BeaugnonRoche Pharma International Informatics, Roche, Boulogne-Billancourt, France.
Yi HuangRoche Pharma International Informatics, Roche (China) Holding Ltd., Shanghai, China.
Elif OzkirimliRoche Pharma International Informatics, F. Hoffmann-La Roche AG, Kaiseraugst, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in biomedical machine learning demonstrate great potential for data-driven techniques in health care and biomedical research. However, this potential has thus far been hampered by both the scarcity of annotated data in the biomedical domain and the diversity of the domain's subfields. While unsupervised learning is capable of finding unknown patterns in the data by design, supervised learning requires human annotation to achieve the desired performance through training. With the latter performing vastly better than the former, the need for annotated datasets is high, but they are costly and laborious to obtain. This review explores a family of approaches existing between the supervised and the unsupervised problem setting. The goal of these algorithms is to make more efficient use of the available labeled data. The advantages and limitations of each approach are addressed and perspectives are provided.

Indexed as

active learningdata annotationdata labelingdata valuemachine learningself-supervised learningsemi-supervised learningzero-shot learning

Identifiers

PMID34950904
PMCPMC8672145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.